176 related articles for article (PubMed ID: 18077445)
1. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
[TBL] [Abstract][Full Text] [Related]
2. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
Weger S; Hammer E; Heilbronn R
FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
[TBL] [Abstract][Full Text] [Related]
3. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
Rao V; Guan B; Mutton LN; Bieberich CJ
J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
[TBL] [Abstract][Full Text] [Related]
4. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
[TBL] [Abstract][Full Text] [Related]
5. Plk1-mediated phosphorylation of Topors regulates p53 stability.
Yang X; Li H; Zhou Z; Wang WH; Deng A; Andrisani O; Liu X
J Biol Chem; 2009 Jul; 284(28):18588-92. PubMed ID: 19473992
[TBL] [Abstract][Full Text] [Related]
6. TOPORS, a Dual E3 Ubiquitin and Sumo1 Ligase, Interacts with 26 S Protease Regulatory Subunit 4, Encoded by the PSMC1 Gene.
Czub B; Shah AZ; Alfano G; Kruczek PM; Chakarova CF; Bhattacharya SS
PLoS One; 2016; 11(2):e0148678. PubMed ID: 26872363
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
[TBL] [Abstract][Full Text] [Related]
8. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
9. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
[TBL] [Abstract][Full Text] [Related]
10. Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity.
Park HJ; Zheng H; Kulkarni D; Kerrigan J; Pungaliya P; Saleem A; Rubin EH
Biochemistry; 2008 Dec; 47(52):13887-96. PubMed ID: 19053840
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.
Markowski MC; Bowen C; Gelmann EP
Cancer Res; 2008 Sep; 68(17):6896-901. PubMed ID: 18757402
[TBL] [Abstract][Full Text] [Related]
12. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
Lei Q; Jiao J; Xin L; Chang CJ; Wang S; Gao J; Gleave ME; Witte ON; Liu X; Wu H
Cancer Cell; 2006 May; 9(5):367-78. PubMed ID: 16697957
[TBL] [Abstract][Full Text] [Related]
13. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
[TBL] [Abstract][Full Text] [Related]
14. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
[TBL] [Abstract][Full Text] [Related]
15. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
16. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
17. TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.
Pungaliya P; Kulkarni D; Park HJ; Marshall H; Zheng H; Lackland H; Saleem A; Rubin EH
J Proteome Res; 2007 Oct; 6(10):3918-23. PubMed ID: 17803295
[TBL] [Abstract][Full Text] [Related]
18. The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.
Bergiers I; Bridoux L; Nguyen N; Twizere JC; Rezsöhazy R
PLoS One; 2013; 8(11):e80387. PubMed ID: 24244684
[TBL] [Abstract][Full Text] [Related]
19. The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.
Saleem A; Dutta J; Malegaonkar D; Rasheed F; Rasheed Z; Rajendra R; Marshall H; Luo M; Li H; Rubin EH
Oncogene; 2004 Jul; 23(31):5293-300. PubMed ID: 15107820
[TBL] [Abstract][Full Text] [Related]
20. [TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].
Daks AA; Petukhov AV; Shuvalov OY; Vasilieva EA; Melino G; Barlev NA; Fedorova OA
Tsitologiia; 2015; 57(12):876-9. PubMed ID: 26995965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]